Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 8, 2015, Pages 1665-1675

  Carvalho, Cristina ^a   Santos, Maria S ^a,b   Oliveira, Catarina R ^a,c   Moreira, Paula I ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Autophagy; Mitochondrial function and biogenesis; Synaptic integrity; Type 2 diabetes

Indexed keywords

ADENINE NUCLEOTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MITOCHONDRIAL PROTEIN; NUCLEAR RESPIRATORY FACTOR 1; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; POSTSYNAPTIC DENSITY PROTEIN 95; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TRANSCRIPTION FACTOR NRF2; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; BIOGENESIS; BODY WEIGHT; BRAIN CELL; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN MITOCHONDRION; BRAIN REGION; BRAIN WEIGHT; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; INSULIN BLOOD LEVEL; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATION CONTROL; SUGAR INTAKE; SYNAPSE; ANIMAL; BRAIN; COMPLICATION; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; ULTRASTRUCTURE;

MUS;

ALZHEIMER DISEASE; ANIMALS; AUTOPHAGY; BIOLOGICAL MARKERS; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; SYNAPSES;

EID: 84929430489     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.05.001     Document Type: Article

References (79)

1. Jayaraman A., Pike C.J. Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr. Diab. Rep. 2014, 14:476.
2. Son S.M., Song H., Byun J., Park K.S., Jang H.C., Park Y.J., Mook-Jung I. Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway. Diabetes 2012, 61(12):3126-3138.
3. Yin W., Signore A.P., Iwai M., Cao G., Gao Y., Chen J. Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain injury. Stroke 2008, 39:3057-3063.
4. Fiskum G. Mitochondrial participation in ischemic and traumatic neural cell death. J. Neurotrauma 2000, 17:843-855.
5. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., Handschin C., Zheng K., Lin J., Yang W., Simon D.K., Bachoo R., Spiegelman B.M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
6. Uittenbogaard M., Chiaramello A. Mitochondrial biogenesis: a therapeutic target for neurodevelopmental disorders and neurodegenerative diseases. Curr. Pharm. Des. 2014, 20(35):5574-5593.
7. Whiteley P.F., Olah K.S. Treatment of cervical intraepithelial neoplasia: experience with the low-voltage diathermy loop. Am. J. Obstet. Gynecol. 1990, 162:1272-1277.
8. Qin W., Haroutunian V., Katsel P., Cardozo C.P., Ho L., Buxbaum J.D., Pasinetti G.M. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch. Neurol. 2009, 66:352-361.
9. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 2001, 21:3017-3023.
10. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19318-19323.
11. Heyward F.D., Walton R.G., Carle M.S., Coleman M.A., Garvey W.T., Sweatt J.D. Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression. Neurobiol. Learn. Mem. 2012, 98:25-32.
12. Higashida K., Kim S.H., Jung S.R., Asaka M., Holloszy J.O., Han D.H. Effects of resveratrol and SIRT1 on PGC-1alpha activity and mitochondrial biogenesis: a reevaluation. PLoS Biol. 2013, 11:e1001603.
13. Santos R.X., Correia S.C., Alves M.G., Oliveira P.F., Cardoso S., Carvalho C., Seica R., Santos M.S., Moreira P.I. Mitochondrial quality control systems sustain brain mitochondrial bioenergetics in early stages of type 2 diabetes. Mol. Cell. Biochem. 2014, 394(1-2):13-22.
14. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
15. Son J.H., Shim J.H., Kim K.H., Ha J.Y., Han J.Y. Neuronal autophagy and neurodegenerative diseases. Exp. Mol. Med. 2012, 44:89-98.
16. Nixon R.A., Wegiel J., Kumar A., Yu W.H., Peterhoff C., Cataldo A., Cuervo A.M. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 2005, 64:113-122.
17. Yu W.H., Kumar A., Peterhoff C., Shapiro Kulnane L., Uchiyama Y., Lamb B.T., Cuervo A.M., Nixon R.A. Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int. J. Biochem. Cell Biol. 2004, 36:2531-2540.
18. Selfridge J.E., L.E, Lu J., Swerdlow R.H. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol. Dis. 2013, 51:3-12.
19. Garcia-Escudero V., Martin-Maestro P., Perry G., Avila J. Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxid. Med. Cell. Longev. 2013, 2013:162152.
20. Masini M., Bugliani M., Lupi R., del Guerra S., Boggi U., Filipponi F., Marselli L., Masiello P., Marchetti P. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 2009, 52:1083-1086.
21. Kaniuk N.A., Kiraly M., Bates H., Vranic M., Volchuk A., Brumell J.H. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 2007, 56:930-939.
22. Son S.M., Song H., Byun J., Park K.S., Jang H.C., Park Y.J., Mook-Jung I. Accumulation of autophagosomes contributes to enhanced amyloidogenic APP processing under insulin-resistant conditions. Autophagy 2012, 8:1842-1844.
23. Zhang T., Yan W., Li Q., Fu J., Liu K., Jia W., Sun X., Liu X. 3-n-butylphthalide (NBP) attenuated neuronal autophagy and amyloid-beta expression in diabetic mice subjected to brain ischemia. Neurol. Res. 2011, 33:396-404.
24. Carvalho C., Cardoso S., Correia S.C., Santos R.X., Santos M.S., Baldeiras I., Oliveira C.R., Moreira P.I. Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 2012, 61:1234-1242.
25. Carvalho C., Machado N., Mota P.C., Correia S.C., Cardoso S., Santos R.X., Santos M.S., Oliveira C.R., Moreira P.I. Type 2 diabetic and Alzheimer's disease mice present similar behavioral, cognitive, and vascular anomalies. J. Alzheimers Dis. 2013, 35:623-635.
26. Gornall A.G., Bardawill C.J., David M.M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 1949, 177:751-766.
27. Estabrook R.W. [7] Mitochondrial respiratory control and the polarographic measurement of ADP:O ratios. Methods in Enzymology 1967, vol. 10:41-47. Academic Press. M.E.P. Ronald, W. Estabrook (Eds.).
28. Kamo N., Muratsugu M., Hongoh R., Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 1979, 49:105-121.
29. Jensen B., Gunther T. The use of tetraphenylphosphonium (TPP+) to measure membrane potentials in mitochondria: membrane binding and respiratory effects. Biophys. J. 1984, 49:105-121.
30. Muratsugu M., Kamo N., Kurihara K., Kobatake Y. Selective electrode for dibenzyl dimethyl ammonium cation as indicator of the membrane potential in biological systems. Biochim. Biophys. Acta 1977, 464:613-619.
31. Arroyo D.S., Gaviglio E.A., Peralta Ramos J.M., Bussi C., Rodriguez-Galan M.C., Iribarren P. Autophagy in inflammation, infection, neurodegeneration and cancer. Int. Immunopharmacol. 2014, 18:55-65.
32. Eskelinen E.L. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects Med. 2006, 27:495-502.
33. White H., Pieper C., Schmader K. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J. Am. Geriatr. Soc. 1998, 46:1223-1227.
34. Power D.A., Noel J., Collins R., O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 2001, 12:167-170.
35. Giordano V., Peluso G., Iannuccelli M., Benatti P., Nicolai R., Calvani M. Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia. Neurochem. Res. 2007, 32:555-567.
36. Zhai C., Cheng J., Mujahid H., Wang H., Kong J., Yin Y., Li J., Zhang Y., Ji X., Chen W. Selective inhibition of PI3K/Akt/mTOR signaling pathway regulates autophagy of macrophage and vulnerability of atherosclerotic plaque. PLoS ONE 2014, 9:e90563.
37. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M.C., Gil R., Pradier L., Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J. Neurochem. 2005, 94:215-225.
38. Caccamo A., Majumder S., Richardson A., Strong R., Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 2010, 285:13107-13120.
39. Spilman P., Podlutskaya N., Hart M.J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., Galvan V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 2010, 5:e9979.
40. Katta A., Karkala S.K., Wu M., Meduru S., Desai D.H., Rice K.M., Blough E.R. Lean and obese Zucker rats exhibit different patterns of p70s6 kinase regulation in the tibialis anterior muscle in response to high-force muscle contraction. Muscle Nerve 2009, 39:503-511.
41. Das A., Durrant D., Koka S., Salloum F.N., Xi L., Kukreja R.C. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression. J. Biol. Chem. 2014, 289:4145-4160.
42. Lipinski M.M., Zheng B., Lu T., Yan Z., Py B.F., Ng A., Xavier R.J., Li C., Yankner B.A., Scherzer C.R., Yuan J. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14164-14169.
43. de Kreutzenberg S.V., Ceolotto G., Papparella I., Bortoluzzi A., Semplicini A., Dalla Man C., Cobelli C., Fadini G.P., Avogaro A. Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 2010, 59:1006-1015.
44. He C., Zhu H., Li H., Zou M.H., Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 2013, 62:1270-1281.
45. Tortosa A., Lopez E., Ferrer I. Bcl-2 and Bax protein expression in Alzheimer's disease. Acta Neuropathol. 1998, 95:407-412.
46. Khandelwal P.J., Herman A.M., Hoe H.S., Rebeck G.W., Moussa C.E. Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models. Hum. Mol. Genet. 2011, 20:2091-2102.
47. Lonskaya I., Hebron M.L., Desforges N.M., Franjie A., Moussa C.E. Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance. EMBO Mol. Med. 2013, 5:1247-1262.
48. Yang L., Li P., Fu S., Calay E.S., Hotamisligil G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010, 11:467-478.
49. Codogno P., Meijer A.J. Autophagy: a potential link between obesity and insulin resistance. Cell Metab. 2010, 11:449-451.
50. Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., Ezaki J., Mizushima N., Ohsumi Y., Uchiyama Y., Kominami E., Tanaka K., Chiba T. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 2005, 169:425-434.
51. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
52. Boland B., Nixon R.A. Neuronal macroautophagy: from development to degeneration. Mol. Aspects Med. 2006, 27:503-519.
53. Nilsson P., Loganathan K., Sekiguchi M., Matsuba Y., Hui K., Tsubuki S., Tanaka M., Iwata N., Saito T., Saido T.C. Abeta secretion and plaque formation depend on autophagy. Cell Rep. 2013, 5:61-69.
54. Carvalho C., Machado N., Mota P., Correia S., Cardoso S., Santos R., Santos M., Oliveira C., Moreira P. Type 2 diabetic and Alzheimer's disease mice present similar behavioral, cognitive and vascular anomalies. J. Alzheimer Dis. 2013, 35.
55. Helps C.R., McGivan J.D. Regulation of glycosylation of Lamp-1 in the bovine renal epithelial cell line NBL-1 by changes in the concentration of extracellular phosphate. Biochem. J. 1994, 303(Pt 2):613-618.
56. Armstrong A., Mattsson N., Appelqvist H., Janefjord C., Sandin L., Agholme L., Olsson B., Svensson S., Blennow K., Zetterberg H., Kagedal K. Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease. Neuromolecular Med. 2014, 16:150-160.
57. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O., Jiang Y., Duff K., Uchiyama Y., Naslund J., Mathews P.M., Cataldo A.M., Nixon R.A. Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 2005, 171:87-98.
58. Nixon R.A., Yang D.S. Autophagy failure in Alzheimer's disease-locating the primary defect. Neurobiol. Dis. 2011, 43:38-45.
59. Athale J., Ulrich A., Chou Macgarvey N., Bartz R.R., Welty-Wolf K.E., Suliman H.B., Piantadosi C.A. Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic. Biol. Med. 2012, 53:1584-1594.
60. Vina J., Gomez-Cabrera M.C., Borras C., Froio T., Sanchis-Gomar F., Martinez-Bello V.E., Pallardo F.V. Mitochondrial biogenesis in exercise and in ageing. Adv. Drug Deliv. Rev. 2009, 61:1369-1374.
61. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88:611-638.
62. Dhar S.S., Wong-Riley M.T. Coupling of energy metabolism and synaptic transmission at the transcriptional level: role of nuclear respiratory factor 1 in regulating both cytochrome c oxidase and NMDA glutamate receptor subunit genes. J. Neurosci. 2009, 29:483-492.
63. Dhar S.S., Liang H.L., Wong-Riley M.T. Transcriptional coupling of synaptic transmission and energy metabolism: role of nuclear respiratory factor 1 in co-regulating neuronal nitric oxide synthase and cytochrome c oxidase genes in neurons. Biochim. Biophys. Acta 2009, 1793:1604-1613.
64. Shen W., Hao J., Tian C., Ren J., Yang L., Li X., Luo C., Cotma C.W., Liu J. A combination of nutriments improves mitochondrial biogenesis and function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. PLoS ONE 2008, 3:e2328.
65. Rato L., Duarte A.I., Tomas G.D., Santos M.S., Moreira P.I., Socorro S., Cavaco J.E., Alves M.G., Oliveira P.F. Pre-diabetes alters testicular PGC1-alpha/SIRT3 axis modulating mitochondrial bioenergetics and oxidative stress. Biochim. Biophys. Acta 2014, 1837:335-344.
66. Santos J.M., Kowluru R.A. Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acid. Invest. Ophthalmol. Vis. Sci. 2011, 52:8791-8798.
67. Pedros I., Petrov D., Allgaier M., Sureda F., Barroso E., Beas-Zarate C., Auladell C., Pallas M., Vazquez-Carrera M., Casadesus G., Folch J., Camins A. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochim. Biophys. Acta 2014, 1842:1556-1566.
68. Robinson A., Grosgen S., Mett J., Zimmer V.C., Haupenthal V.J., Hundsdorfer B., Stahlmann C.P., Slobodskoy Y., Muller U.C., Hartmann T., Stein R., Grimm M.O. Upregulation of PGC-1alpha expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP. Aging Cell 2014, 13:263-272.
69. Tan Y., Ichikawa T., Li J., Si Q., Yang H., Chen X., Goldblatt C.S., Meyer C.J., Li X., Cai L., Cui T. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 2011, 60:625-633.
70. Ongwijitwat S., Wong-Riley M.T. Is nuclear respiratory factor 2 a master transcriptional coordinator for all ten nuclear-encoded cytochrome c oxidase subunits in neurons?. Gene 2005, 360:65-77.
71. Santos J.M., Kowluru R.A. Impaired transport of mitochondrial transcription factor A (TFAM) and the metabolic memory phenomenon associated with the progression of diabetic retinopathy. Diabetes Metab. Res. Rev. 2013, 29:204-213.
72. Magarinos A.M., Jain K., Blount E.D., Reagan L., Smith B.H., McEwen B.S. Peritoneal implantation of macroencapsulated porcine pancreatic islets in diabetic rats ameliorates severe hyperglycemia and prevents retraction and simplification of hippocampal dendrites. Brain Res. 2001, 902:282-287.
73. King M.R., Anderson N.J., Guernsey L.S., Jolivalt C.G. Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice. J. Neurosci. Res. 2013, 91:506-514.
74. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
75. Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., Cole G.M. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am. J. Pathol. 2004, 165:1809-1817.
76. Elias G.M., Funke L., Stein V., Grant S.G., Bredt D.S., Nicoll R.A. Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins. Neuron 2006, 52:307-320.
77. Kwon S.E., Chapman E.R. Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron 2011, 70:847-854.
78. Greber S., Lubec G., Cairns N., Fountoulakis M. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis 1999, 20:928-934.
79. Gaspar J.M., Baptista F.I., Galvao J., Castilho A.F., Cunha R.A., Ambrosio A.F. Diabetes differentially affects the content of exocytotic proteins in hippocampal and retinal nerve terminals. Neuroscience 2010, 169:1589-1600.